CA
ONCY

Clearstead Advisors’s Oncolytics Biotech ONCY Stock Holding History

Clearstead Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37K Buy
+39,000
New +$36.2K ﹤0.01% 1598

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Clearstead Advisors's ONCY Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 39,000 shares worth $37K. The stake represents ﹤0.01% of the portfolio and ranks #1598 among its holdings.

28 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Clearstead Advisors held 39,000 shares of Oncolytics Biotech worth $37K as of Q2 2026.
  • Oncolytics Biotech was a new Clearstead Advisors position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1598 holding.
  • 28 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.